Moderna, Inc. (MRNA) Balance Sheet Annual - Discounting Cash Flows
MRNA
Moderna, Inc.
MRNA (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-02-21 2024-02-23 2023-02-24 2022-02-25 2021-02-26 2020-02-27 2019-03-13 2017-12-31 2016-12-31
Total Current Assets 8,099 10,325 13,431 16,071 6,298 1,129 1,563 783.2 1,087
Cash and Short Term Investments 7,025 8,604 9,902 10,727 4,608 1,103 1,521 756 1,058
Cash & Equivalents 1,927 2,907 3,205 6,848 2,624 235.9 658.4 134.9 50.08
Short Term Investments 5,098 5,697 6,697 3,879 1,984 867.1 863.1 621.2 1,008
Receivables 592 1,081 1,685 3,323 1,408 16.3 30.58 18.4 17.95
Inventory 117 202 949 1,441 47 0 0 0 0
Other Current Assets 365 438 895 580 235 9.51 11 8.79 11.06
Total Assets 14,142 18,426 25,858 24,669 7,337 1,589 1,962 1,084 1,417
Total Non-Current Assets 6,043 8,101 12,427 8,598 1,039 460.6 399.1 301.3 330
Property, Plant and Equipment 2,955 2,658 2,139 1,383 387 287.9 212 139 81.21
Goodwill and Intangible Assets 92 96 0 0 0 0 0 0 0
Goodwill 52 52 0 0 0 0 0 0 0
Intangible Assets 40 44 0 0 0 0 0 0 0
Long Term Investments 2,508 4,743 8,360 6,843 639 160 173 145.9 236.6
Deferred Tax Assets 81 81 982 326 0 0 0 0 0
Other Long Term Assets 407 523 946 46 13 12.72 14.18 16.38 12.23
Total Current Liabilities 2,206 3,015 4,923 9,128 4,389 143.1 222.8 191.5 162.8
Accounts Payable 405 520 487 302 18 7.09 31.21 20.73 28.16
Notes Payable/Short Term Debt 37 25 196 211 30 0 0 0 0
Tax Payables 3 63 48 876 0 0 0 0 0
Deferred Revenue 153 568 2,038 6,253 3,867 63.31 109.1 96.74 107.7
Other Current Liabilities 1,608 1,839 2,154 1,486 474 72.72 82.54 74 26.91
Total Liabilities 3,241 4,572 6,735 10,524 4,776 414.6 431.9 459.2 575.3
Total Non-Current Liabilities 1,035 1,557 1,812 1,396 387 271.5 209.1 267.7 412.5
Total Long Term Debt 710 1,218 1,004 705 207 132.4 33.49 15.69 12.5
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0
Deferred Revenue Non-Current 58 83 673 615 177 139 165.4 242.9 394.2
Capital Lease Obligations 747 1,243 1,200 916 237 132.4 33.49 15.69 12.5
Other Long Term Liabilities -480 -987 -1,065 -840 -234 -132.2 -23.23 -6.57 -6.74
Total Equity 10,901 13,854 19,123 14,145 2,561 1,175 1,530 625.3 841.9
Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 10,901 13,854 19,123 14,145 2,561 1,175 1,530 625.3 841.9
Retained Earnings 10,045 13,606 18,320 9,958 -2,244 -1,496 -1,007 -621.9 -365.7
Accumulated Other Earnings -10 -123 -370 -24 3 1.8 -1.32 -1.16 -0.403
Common Stock 0 0 0 0 0 0.034 0.033 0.006 0.006
Preferred Stock 0 0 0 0 0 0 0 1,177 1,177
Additional Paid in Capital 866 371 1,173 4,211 4,802 2,669 2,538 71.68 31.3
Total Liabilities & Total Equity 14,142 18,426 25,858 24,669 7,337 1,589 1,962 1,084 1,417
Total Liabilities & Shareholders' Equity 14,142 18,426 25,858 24,669 7,337 1,589 1,962 1,084 1,417
Total Investments 7,606 10,440 15,057 10,722 2,623 1,027 1,036 767 1,245
Total Debt 747 1,243 1,200 916 237 132.4 33.49 15.69 12.5
Net Debt -1,180 -1,664 -2,005 -5,932 -2,387 -103.5 -624.9 -119.2 -37.58
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program